Skip to main content

Eupraxia Pharmaceuticals Inc.

EPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001581178

No open-market purchases or sales by Eupraxia Pharmaceuticals Inc. insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $163.6M in total; no superinvestor holds it.

Members of Congress who traded EPRX

No member of Congress has reported a trade in Eupraxia Pharmaceuticals Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.